BioSpectrum Asia launched the APAC Bioeconomy Index 2026, the first independent, region-native benchmark of Asia-Pacific...
The Korea Regulatory Science Center (K-RSC), led by Director General Oh Jae-ho, has signed a Memorandum of Understanding...
A growing burden demands a new approach Cardiac ablation treats AFib by targeting heart cells that send erratic signals...
A new way for hard-to-treat cancer cells to protect themselves from being killed by anti-cancer drugs has been found. Th...
The National Initiative for RNA Biology and its Applications (NIRBA) has officially opened its new Hub at the National U...
IHH Healthcare recently hosted the second edition of its flagship regional leadership conference FutureHealth.Now in Sin...
Why is collaborative philanthropy important in addressing mosquito-borne diseases and wider public health threats in Asi...
London School of Business & Finance (LSBF) Singapore Campus has announced the launch of its School of Health Science...
Tikva Allocell, a Singapore-based biotechnology startup developing engineered, allogeneic (donor-derived) cell therapies...
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have developed a ...
Menarini Asia-Pacific has announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distri...
Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
The National University Hospital (NUH) in Singapore is set to expand the use of wearable technology after a successful p...
Singapore will contribute $2 million to support the ongoing Ebola Bundibugyo Virus Disease (BVD) outbreak response in th...
ARIA Bioscience, Singapore’s longevity biotech commercialisation firm, is collaborating with the A*STAR Institute ...
Foundation Healthcare, an integrated private healthcare platform in Singapore, has registered its prospectus with the Mo...
Most AI foundation models used in healthcare today are trained on data from Western populations, which can limit the acc...
Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by ...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
South Korea-based Neurophet, an artificial intelligence (AI) solution company for brain disorders diagnosis and treatmen...
ALR Technologies SG has entered into a Letter of Intent (LOI) to acquire 100% equity of CGM Medical Technology Singapore...
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings, Singapo...
Biobot Surgical, a Singapore-based medical technology company developing robotic-assisted systems for prostate cancer di...
As healthcare systems across Asia accelerate investments in artificial intelligence (AI), digital platforms, and data-dr...
Healthcare systems across Southeast Asia are navigating a period of unprecedented change. Ageing populations, rising hea...
